We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

707 hedge funds and large institutions have $17.7B invested in Charles River Laboratories in 2021 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 245 increasing their positions, 264 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $105M | Put options by funds: $57.7M

66% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 64

5% more funds holding

Funds holding: 676 → 707 (+31)

0.56% more ownership

Funds ownership: 92.91% → 93.47% (+0.56%)

7% less repeat investments, than reductions

Existing positions increased: 245 | Existing positions reduced: 264

8% less capital invested

Capital invested by funds: $19.3B → $17.7B (-$1.58B)

25% less funds holding in top 10

Funds holding in top 10: 20 → 15 (-5)

Holders
707
Holders Change
+31
Holders Change %
+4.59%
% of All Funds
10.88%
Holding in Top 10
15
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-25%
% of All Funds
0.23%
New
106
Increased
245
Reduced
264
Closed
64
Calls
$105M
Puts
$57.7M
Net Calls
+$47.4M
Net Calls Change
+$15.9M

Top Buyers

1
ClearBridge Investments
ClearBridge Investments
New York
+$210M
2
MCM
Melvin Capital Management
New York
+$112M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$82.6M
4
Marshall Wace
Marshall Wace
United Kingdom
+$59.2M
5
William Blair Investment Management
William Blair Investment Management
Illinois
+$51.9M

Top Sellers

1
Ameriprise
Ameriprise
Minnesota
-$90.1M
2
Victory Capital Management
Victory Capital Management
Texas
-$72.1M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$66.6M
4
CIM
Confluence Investment Management
Missouri
-$51.8M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
-$45.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.21B -$20.6M -52,925 -0.9%
BlackRock
2
BlackRock
New York
$1.91B -$2.98M -7,667 -0.2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.04B -$20.9M -53,784 -2%
State Street
4
State Street
Massachusetts
$765M +$28.5M +73,315 +4%
Kayne Anderson Rudnick Investment Management
5
Kayne Anderson Rudnick Investment Management
California
$585M +$27.5M +70,850 +5%
Invesco
6
Invesco
Georgia
$532M -$21.1M -54,267 -4%
Massachusetts Financial Services
7
Massachusetts Financial Services
Massachusetts
$487M -$25.3M -65,131 -5%
William Blair Investment Management
8
William Blair Investment Management
Illinois
$406M +$51.9M +133,654 +14%
ClearBridge Investments
9
ClearBridge Investments
New York
$402M +$210M +540,217 +102%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$348M +$5.28M +13,586 +1%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$273M +$2.45M +6,303 +0.9%
MCM
12
Melvin Capital Management
New York
$249M +$112M +287,006 +77%
Brown Advisory
13
Brown Advisory
Maryland
$241M -$18.7M -48,216 -7%
Luther King Capital Management (LKCM)
14
Luther King Capital Management (LKCM)
Texas
$209M +$3.56M +9,159 +2%
Bank of America
15
Bank of America
North Carolina
$201M -$15.9M -40,892 -7%
Fidelity International
16
Fidelity International
Bermuda
$201M +$3.11M +7,994 +2%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$198M +$21.3M +54,853 +12%
Northern Trust
18
Northern Trust
Illinois
$195M -$3.83M -9,860 -2%
Norges Bank
19
Norges Bank
Norway
$191M +$6.48M +16,689 +3%
Franklin Resources
20
Franklin Resources
California
$186M +$27.2M +70,113 +17%
Marshall Wace
21
Marshall Wace
United Kingdom
$171M +$59.2M +152,258 +50%
CAM
22
Congress Asset Management
Massachusetts
$163M -$5.36M -13,787 -3%
Viking Global Investors
23
Viking Global Investors
Connecticut
$147M +$82.6M +212,726 +120%
TCM
24
TimesSquare Capital Management
New York
$143M +$1.21M +3,104 +0.8%
Primecap Management
25
Primecap Management
California
$135M -$2.74M -7,040 -2%
1
2 3 4 5

CRL Hedge Fund Activity: Q4 2021 in Review

707 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2021, worth a combined $17.7B — down 8.2% from $19.3B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new CRL positions and 64 closed out — a net gain of 42 holders — while 245 added to existing stakes and 264 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $210M. The largest seller was Ameriprise, cutting an estimated $90.1M.

  • 707 institutional investors held Charles River Laboratories (CRL) as of Q4 2021, up from 676 in Q3 2021.
  • Funds reported $17.7B of Charles River Laboratories stock for Q4 2021, down 8.2% quarter-over-quarter.
  • 106 funds opened new Charles River Laboratories positions in Q4 2021 and 64 closed out, a net change of +42 holders.
  • The largest Charles River Laboratories buyer in Q4 2021 was ClearBridge Investments, an estimated $210M added.
  • The largest Charles River Laboratories seller in Q4 2021 was Ameriprise, an estimated $90.1M sold.

Based on aggregated 13F filings for Q4 2021.